DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: October 14, 2014
Period of Report: October 14, 2014
Accession Number: 0001193125-14-371230

View Document ↗ View on SEC.gov ↗